Norris ORIEN Total Cancer Care

Part of paid clinical trials in Los Angeles, California.

Sponsor
University of Southern California
Study ID
NCT02970045
Status
Recruiting
Apply to this trial

Conditions

  • Cancer Risk
  • Malignant Neoplasm

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Biospecimen Collection — PROCEDURE
    Undergo collection of blood, tissue, and other biological samples
  • Evaluation of Cancer Risk Factors — PROCEDURE
    Ancillary studies
  • Medical Chart Review — OTHER
    Review of medical chart
  • Quality-of-Life Assessment — OTHER
    Ancillary studies
  • Questionnaire Administration — OTHER
    Ancillary studies

Study Details

This research trial collects biological samples and clinical information to create a repository of data from patients with cancer or a predisposition for cancer. Combining genetic information from biological samples and clinical data may lead to more knowledge about why certain cancers respond to treatment and help create more personalized medicine.

Key Dates

Start date
May 2, 2016
Status verified
Apr 2026
Primary completion
May 2, 2036
Completion
May 2, 2037

Study Design

Enrollment
10,000 participants (estimated)

Arms

  • Arm: Ancillary-Correlative (biospecimen collection)
    Patients undergo collection of blood during a regular care visit or not up to 4 times a year. Extra tissue is collected after removal during standard of care surgery and patients may undergo additional tumor sampling (needle passes) at the time of planned diagnostic biopsies. During bone marrow biopsy, the doctor may reposition the needle up to 3 times, and bone marrow for research will not be collected more than 4 times per year. Patients may undergo additional collection of other biological samples such as saliva, sputum, urine, feces, hair, and surface skin swabs for analysis. Patients also receive surveys or questionnaires to collect demographics, medical, family, and nutritional history, cancer predisposing risk factors, quality of life data, and quality of care data.

Primary Outcome Measure

Number of biospecimen collected for a centralized repository that is linked to clinical data [ Time Frame: Up to 21 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
USC / Norris Comprehensive Cancer CenterLos AngelesCalifornia90033
Melissa Woodhouse, MHA, MPH
[email protected]
323-865-0489
Bodour Salhia, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Los Angeles, CA

By research site
USC / Norris Comprehensive Cancer Center· Los Angeles, CA

Related Studies